Scrub Typhus Epidemiology and Clinical Management

Summary

Scrub typhus is an acute febrile illness caused by the obligate intracellular bacterium Orientia tsutsugamushi. Transmitted by larval trombiculid mites (‘chiggers’), the disease is endemic throughout the Asia-Pacific ‘Tsutsugamushi Triangle’ and has emerging foci in South America and Africa. Estimates exceed one million cases per annum, with expanding geographic reach driven by environmental change, urban encroachment and increased human mobility. Clinical presentation is often non-specific: high fever, myalgia, headache and a characteristic eschar may occur, but absence of pathognomonic signs complicates diagnosis. Severe complications—meningoencephalitis, acute respiratory distress and multiorgan failure—contribute to substantial morbidity and mortality when treatment is delayed. Epidemiological surveillance is hampered by inconsistent reporting, antigenic heterogeneity of O. tsutsugamushi strains and limited laboratory capacity in resource-constrained settings. Empirical therapy with doxycycline or azithromycin remains the mainstay of management, yet diagnostic uncertainty and rising reports of azithromycin resistance in some regions underscore the need for improved point-of-care tests. Control measures focus on personal protective behaviour, vector habitat management and timely case detection. Despite decades of research, no licensed vaccine exists and gaps persist in understanding protective immunity, strain diversity and long-term sequelae. A coordinated global strategy coupling enhanced surveillance, standardised diagnostics and vaccine development is essential to reduce the burden of scrub typhus.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Scrub Typhus Epidemiology and Clinical Management publication trend

The graph below shows the total number of articles in scrub typhus epidemiology and clinical management across all publications each year (not limited to Nature Index journals).

Technical terms

Orientia tsutsugamushi: Intracellular bacterium that causes scrub typhus.

Trombiculid mites: Larval mites (‘chiggers’) that serve as both reservoir and vector for O. tsutsugamushi.

Eschar: Necrotic skin lesion at mite bite site, often a diagnostic clue in scrub typhus.

Meningoencephalitis: Inflammation of both the meninges and brain parenchyma, a severe complication of infection.

Area under the curve (AUC): Measure of diagnostic or predictive model performance; higher values indicate better discrimination.

References

  1. Construction and validation of a predictive model for meningoencephalitis in pediatric scrub typhus based on machine learning algorithms. Emerging Microbes & Infections (2025).
  2. A scrub typhus vaccine presents a challenging unmet need. npj Vaccines (2023).
  3. Brain transcriptomics reveal the activation of neuroinflammation pathways during acute Orientia tsutsugamushi infection in mice. Frontiers in Immunology (2023).
  4. A Review of Scrub Typhus (Orientia tsutsugamushi and Related Organisms): Then, Now, and Tomorrow. Tropical Medicine and Infectious Disease (2018).
  5. Scrub Typhus: No Longer Restricted to the Tsutsugamushi Triangle. Tropical Medicine and Infectious Disease (2018).

About these summaries

This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.

Nature Index 2026 Regenerative medicine

Regenerative medicine has the potential to transform the treatment of chronic and life-threatening diseases. But major challenges remain, such as overcoming immune rejection and ensuring that new therapies are developed using more inclusive data sets. In this supplement, we explore the discoveries that are driving the field, the barriers that could limit its progress, and the teams and institutions that are making their mark.

Nature Index 2026 Regenerative medicine
Access for free
Nature Strategy Reports
Turn complex research questions into confident strategic decisions 

When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.

  • Benchmark your performance against global peers using robust, methodologically sound analysis.

  • Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.

  • Gain tailored, decision-ready recommendations aligned to your strategic priorities.

Talk to us to learn more about our data dashboards and bespoke strategy reports.

Nature Masterclasses
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.

Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:

  • Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.

  • Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.

  • Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.

Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.